KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Fulgent Genetics (FLGT) over the last 11 years, with Q3 2025 value amounting to -$6.5 million.

  • Fulgent Genetics' Other Operating Expenses rose 5494.6% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year decrease of 7871.76%. This contributed to the annual value of $44.2 million for FY2024, which is 7392.39% down from last year.
  • Latest data reveals that Fulgent Genetics reported Other Operating Expenses of -$6.5 million as of Q3 2025, which was up 5494.6% from $14.3 million recorded in Q2 2025.
  • Fulgent Genetics' Other Operating Expenses' 5-year high stood at $132.7 million during Q4 2023, with a 5-year trough of -$23.8 million in Q4 2022.
  • Moreover, its 5-year median value for Other Operating Expenses was $11.0 million (2024), whereas its average is $26.5 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 245432.52% in 2021, then crashed by 21912.86% in 2024.
  • Quarter analysis of 5 years shows Fulgent Genetics' Other Operating Expenses stood at $89.7 million in 2021, then tumbled by 126.57% to -$23.8 million in 2022, then surged by 656.78% to $132.7 million in 2023, then plummeted by 91.31% to $11.5 million in 2024, then tumbled by 156.41% to -$6.5 million in 2025.
  • Its Other Operating Expenses was -$6.5 million in Q3 2025, compared to $14.3 million in Q2 2025 and $10.5 million in Q1 2025.